Pacific Shuanglin Bio‑phar (000403.SZ) – Market Snapshot
Trading performance The share price of Pacific Shuanglin Bio‑phar remained unchanged (0 %) during the 24‑hour period ending at 12:05 PM Central Europe on Wednesday 21 March.
Current price The stock trades at approximately CNY 9.75 on major Shenzhen exchanges.
Share supply and market value Total shares outstanding: 937.2 million. Market capitalization: CNY 9.10 billion.
Trading volume In the last 24 hours, CNY 39.2 million worth of shares were traded.
Recent performance Compared with the end of last month, the stock has decreased by 2.31 %.
Technical indicators • 200‑day simple moving average: CNY 10.42. • 52‑week high: CNY 16.42 (recorded 14 November 2025). • 52‑week low: CNY 8.54 (recorded 29 June 2026).
Related Stock Movements (24‑hour period)
| Ticker | Trading change | Current price (CNY) | Market cap (CNY) | P/E ratio |
|---|---|---|---|---|
| Weaver Network (603039.SS) | Flat 0 % | 34.75 | 10.90 bn | 32.33 |
| Wangfujing (600859.SS) | Flat 0 % | 9.57 | 10.90 bn | — |
| Jiamei Food Packaging Chuz (002969.SZ) | Flat 0 % | 9.83 | 10.90 bn | 84.43 |
| Infovision Optoelectronics (688055.SS) | Flat 0 % | 3.26 | 10.90 bn | — |
| Zhuzhou Huarui Precision C (688059.SS) | Flat 0 % | 77.40 | 10.90 bn | 33.10 |
Company Profile
Pacific Shuanglin Bio‑pharmacy Co., Ltd. is a Chinese healthcare company focused on the pharmaceutical sector. Founded in 1996 and headquartered in Zhanjiang, the firm manufactures a range of blood‑derived products, including human albumin, intravenous and human immunoglobulin, tetanus and rabies immunoglobulin. The company also engages in biotechnology investment activities. Pacific Shuanglin Bio‑pharmacy’s shares are listed on the Shenzhen Stock Exchange, with its IPO occurring on 7 June 1996.
